Ventripoint Diagnostics Stock Analysis
| VPTDF Stock | USD 0.09 0 1.12% |
VentriPoint Diagnostics holds a debt-to-equity ratio of 0.022. VentriPoint Diagnostics' financial risk is the risk to VentriPoint Diagnostics stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
VentriPoint Diagnostics' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. VentriPoint Diagnostics' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps VentriPoint Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect VentriPoint Diagnostics' stakeholders.
For many companies, including VentriPoint Diagnostics, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for VentriPoint Diagnostics, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, VentriPoint Diagnostics' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that VentriPoint Diagnostics' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which VentriPoint Diagnostics is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of VentriPoint Diagnostics to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, VentriPoint Diagnostics is said to be less leveraged. If creditors hold a majority of VentriPoint Diagnostics' assets, the Company is said to be highly leveraged.
VentriPoint Diagnostics is overvalued with Real Value of 0.0729 and Hype Value of 0.1. The main objective of VentriPoint Diagnostics pink sheet analysis is to determine its intrinsic value, which is an estimate of what VentriPoint Diagnostics is worth, separate from its market price. There are two main types of VentriPoint Diagnostics' stock analysis: fundamental analysis and technical analysis.
The VentriPoint Diagnostics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and VentriPoint Diagnostics' ongoing operational relationships across important fundamental and technical indicators.
VentriPoint |
VentriPoint Pink Sheet Analysis Notes
The company recorded a loss per share of 0.02. VentriPoint Diagnostics had not issued any dividends in recent years. The entity had 1:10 split on the 7th of December 2015. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company was incorporated in 2004 and is based in Toronto, Canada. Ventripoint Diagnostics is traded on OTC Exchange in the United States.The quote for VentriPoint Diagnostics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call BASc ICDD at 416-848-4156 or visit https://www.ventripoint.com.VentriPoint Diagnostics Investment Alerts
| VentriPoint Diagnostics is way too risky over 90 days horizon | |
| VentriPoint Diagnostics has some characteristics of a very speculative penny stock | |
| VentriPoint Diagnostics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (3.88 M) with loss before overhead, payroll, taxes, and interest of (6.27 K). | |
| VentriPoint Diagnostics has accumulated about 7.29 M in cash with (3.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. |
VentriPoint Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 32.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VentriPoint Diagnostics's market, we take the total number of its shares issued and multiply it by VentriPoint Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 5th of February, VentriPoint Diagnostics has the Coefficient Of Variation of 1071.75, risk adjusted performance of 0.0788, and Semi Deviation of 4.48. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of VentriPoint Diagnostics, as well as the relationship between them. Please validate VentriPoint Diagnostics variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if VentriPoint Diagnostics is priced more or less accurately, providing market reflects its prevalent price of 0.09 per share. As VentriPoint Diagnostics appears to be a penny stock we also recommend to double-check its total risk alpha numbers.VentriPoint Diagnostics Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze VentriPoint Diagnostics price data points by creating a series of averages of different subsets of VentriPoint Diagnostics entire price series.
VentriPoint Diagnostics Predictive Daily Indicators
VentriPoint Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of VentriPoint Diagnostics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 14110.61 | |||
| Daily Balance Of Power | 0.1563 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.0869 | |||
| Day Typical Price | 0.0879 | |||
| Price Action Indicator | 0.0036 | |||
| Period Momentum Indicator | 0.001 |
VentriPoint Diagnostics Forecast Models
VentriPoint Diagnostics' time-series forecasting models are one of many VentriPoint Diagnostics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VentriPoint Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.VentriPoint Diagnostics Debt to Cash Allocation
Many companies such as VentriPoint Diagnostics, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
VentriPoint Diagnostics has accumulated 125.38 K in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. VentriPoint Diagnostics has a current ratio of 6.61, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist VentriPoint Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, VentriPoint Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VentriPoint Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VentriPoint to invest in growth at high rates of return. When we think about VentriPoint Diagnostics' use of debt, we should always consider it together with cash and equity.VentriPoint Diagnostics Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the VentriPoint Diagnostics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of VentriPoint Diagnostics, which in turn will lower the firm's financial flexibility.About VentriPoint Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how VentriPoint Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VentriPoint shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as VentriPoint Diagnostics. By using and applying VentriPoint Pink Sheet analysis, traders can create a robust methodology for identifying VentriPoint entry and exit points for their positions.
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company was incorporated in 2004 and is based in Toronto, Canada. Ventripoint Diagnostics is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding VentriPoint Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Complementary Tools for VentriPoint Pink Sheet analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |